Key Points Staphylococcus is an increasingly important cause of IE in LMICs, and is the leading cause of IE in UMICs RHD remains the major underlying cardiac pathology of IE in LMICs, identified in almost half of reported cases The rate of microorganism non-identification is high, reaching up to 60% of IE cases in LMICs, and hampering diagnosis and treatment Rates of access to surgery in UMICs for complicated IE are as high as in HICs, but remain dismal in lower-middle income countries
SynopsisInfective endocarditis (IE) is a rare, life-threatening disease with a mortality rate of upto 25% and significant debilitating morbidities. Although much has been reported on contemporary IE in high income countries, conclusions on the state of IE in low and middle income countries (LMICs) are based on studies conducted before the year 2000. Furthermore, unique challenges in the diagnosis and management of IE persist in LMICs. This article is a review of IE studies conducted in LMICs documenting clinical experiences from the year 2000 to present. We present the causes of IE, management of patients with IE and the prevailing challenges in diagnosis and treatment of IE in LMICs.